Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,285,755 papers from all fields of science
Search
Sign In
Create Free Account
lansoprazole 30 MG Disintegrating Oral Tablet [Prevacid]
Known as:
Prevacid SoluTab 30 MG Delayed Release Disintegrating Oral Tablet
, Prevacid 30 MG Delayed Release Disintegrating Oral Tablet
, LANSOPRAZOLE 30 mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE [Prevacid]
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
24 relations
Aspartame
Crospovidone
Disintegrating Oral Tablet
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
PREVACID (lansoprazole) Delayed-Release Capsules PREVACID SoluTab (lansoprazole) Delayed-Release Orally Disintegrating Tablets For oral administration Initial U.S. Approval: 1995…
2012
Corpus ID: 45208788
-----------------------------DRUG INTERACTIONS-------------------------- • Atazanavir: Do not co-administer with atazanavir. (7…
Expand
2008
2008
Does generic substitution always make sense?
P. Greenberg
Journal of Medical Economics
2008
Corpus ID: 8653161
Over the past 25 years, as healthcare payers and providers have attempted to rein in increasing drug costs, generic medications…
Expand
2006
2006
Polyvalence croissante des IPP : La place du lansoprazole en comprimés à désintégration orale
David Morgan
,
Stephen Wolman
,
G. Aumais
,
Hôpital Maisonneuve-Rosemont
,
Ronald J Bridges
,
Allan Cockeram
2006
Corpus ID: 73350539
le clinicien novembre 2006 Depuis leur avenement au cours des annees 1990, les inhibiteurs de la pompe a protons (IPP) sont…
Expand
2006
2006
Lansoprazole regimens that sustain intragastric pH >6.0: an evaluation of intermittent oral and continuous intravenous infusion dosages
D. Metz
,
F. Amer
,
B. Hunt
,
M. Vakily
,
M. Kukulka
,
N. Samra
Alimentary Pharmacology and Therapeutics
2006
Corpus ID: 28868320
Background Orally and intravenously administered proton pump inhibitors have been shown to reduce rebleeding rates, surgery and…
Expand
Review
2001
Review
2001
What's new: newly approved drugs for children.
M. Abbott
,
R. H. Levin
Pediatrics in review
2001
Corpus ID: 27146937
Review
1998
Review
1998
Gastroesophageal reflux disease.
D. Stevens
,
N. P. Beckey
,
W. F. Siebert
Lippincott's primary care practice
1998
Corpus ID: 29676016
Proton pump inhibitors (PPI) and histamine 2 (H2) antagonists decrease the amount of acid produced in the stomach and are used to…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE